×
About 144 results

ALLMedicine Acneiform Eruptions Center

Research & Reviews  69 results

Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.
https://doi.org/10.1136/postgradmedj-2020-137756
Postgraduate Medical Journal; Priyam P, Sil A et. al.

Apr 16th, 2020 - Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.|2020|Priyam P,Sil A,Bhanja DB,Mondol DK,|

Twelve cases of acneiform eruptions while on anti-CTLA4 therapy.
https://doi.org/10.1007/s00520-020-05381-5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer; Welborn M, Kubicki SL et. al.

Mar 9th, 2020 - We present the first detailed report of acneiform eruptions in patients on CTLA-4 inhibitor therapy. Acneiform eruptions commonly occur (up to 75-100%) as a cutaneous adverse event associated with EGFR inhibition; however, acneiform eruptions have...

Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.

Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.

Follicular occlusion disorders in Down syndrome patients.
https://doi.org/10.1111/pde.14012
Pediatric Dermatology REFERENCES; Firsowicz M, Boyd M et. al.

Oct 18th, 2019 - Disorders involving follicular occlusion, such as hidradenitis suppurativa, folliculitis, acneiform eruptions, and pilonidal cysts, have shown an increased prevalence in the Down syndrome (DS) population, but there are limited published data exami...

A retrospective chart review on oral retinoids as a treatment for epidermal growth fact...
https://doi.org/10.1016/j.jaad.2019.10.003
Journal of the American Academy of Dermatology; Andrews ED, Garg N et. al.

Oct 11th, 2019 - A retrospective chart review on oral retinoids as a treatment for epidermal growth factor receptor inhibitor- and mitogen-activated protein kinase kinase inhibitor-induced acneiform eruptions.|2019|Andrews ED,Garg N,Patel AB,|

see more →

Clinicaltrials.gov  71 results

Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.
https://doi.org/10.1136/postgradmedj-2020-137756
Postgraduate Medical Journal; Priyam P, Sil A et. al.

Apr 16th, 2020 - Propranolol-induced acneiform eruptions: revisiting a rare cutaneous side effect.|2020|Priyam P,Sil A,Bhanja DB,Mondol DK,|

Twelve cases of acneiform eruptions while on anti-CTLA4 therapy.
https://doi.org/10.1007/s00520-020-05381-5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer; Welborn M, Kubicki SL et. al.

Mar 9th, 2020 - We present the first detailed report of acneiform eruptions in patients on CTLA-4 inhibitor therapy. Acneiform eruptions commonly occur (up to 75-100%) as a cutaneous adverse event associated with EGFR inhibition; however, acneiform eruptions have...

Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.

Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.

Follicular occlusion disorders in Down syndrome patients.
https://doi.org/10.1111/pde.14012
Pediatric Dermatology REFERENCES; Firsowicz M, Boyd M et. al.

Oct 18th, 2019 - Disorders involving follicular occlusion, such as hidradenitis suppurativa, folliculitis, acneiform eruptions, and pilonidal cysts, have shown an increased prevalence in the Down syndrome (DS) population, but there are limited published data exami...

A retrospective chart review on oral retinoids as a treatment for epidermal growth fact...
https://doi.org/10.1016/j.jaad.2019.10.003
Journal of the American Academy of Dermatology; Andrews ED, Garg N et. al.

Oct 11th, 2019 - A retrospective chart review on oral retinoids as a treatment for epidermal growth factor receptor inhibitor- and mitogen-activated protein kinase kinase inhibitor-induced acneiform eruptions.|2019|Andrews ED,Garg N,Patel AB,|

see more →

News  4 results

Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.

Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.

Cutaneous Side-effects of EGFR Inhibitors and Their Management
https://www.medscape.com/viewarticle/742542

Abstract and Introduction Abstract Epidermal growth factor receptor (EGFR) inhibitors are an increasingly important treatment option for metastasized cancer in patients. In addition to the pivotal role of EGFR in the development and progression of...

see more →